| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 935.30M | 984.60M | 1.19B | 1.55B | 1.31B |
| Gross Profit | 615.80M | 694.80M | 850.10M | 1.06B | 861.10M |
| EBITDA | 211.50M | 249.20M | 330.10M | 461.90M | 357.70M |
| Net Income | 78.60M | 121.20M | 184.80M | 293.80M | 212.50M |
Balance Sheet | |||||
| Total Assets | 3.46B | 3.42B | 3.37B | 3.21B | 2.99B |
| Cash, Cash Equivalents and Short-Term Investments | 78.00M | 83.10M | 93.00M | 73.70M | 116.30M |
| Total Debt | 768.30M | 758.64M | 742.80M | 607.00M | 467.40M |
| Total Liabilities | 1.53B | 1.49B | 1.53B | 1.45B | 1.33B |
| Stockholders Equity | 1.93B | 1.93B | 1.85B | 1.75B | 1.66B |
Cash Flow | |||||
| Free Cash Flow | 53.90M | 70.40M | 13.70M | 42.20M | 90.30M |
| Operating Cash Flow | 90.90M | 70.40M | 94.60M | 124.10M | 144.80M |
| Investing Cash Flow | -40.50M | -48.40M | -80.40M | -59.30M | -65.70M |
| Financing Cash Flow | -53.40M | -31.90M | 7.20M | -107.20M | -175.10M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | €531.89M | 10.73 | 7.22% | 2.31% | 3.18% | 4.47% | |
71 Outperform | €16.05B | 11.39 | 10.50% | 6.45% | -10.26% | 28.54% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
56 Neutral | €319.93M | 35.01 | 2.68% | ― | -8.69% | -5.22% | |
55 Neutral | €2.38B | 30.43 | 4.83% | 4.18% | -5.01% | -35.95% | |
51 Neutral | €186.12M | 11.52 | 6.04% | 2.83% | -8.67% | -31.83% | |
42 Neutral | €100.78M | 70.28 | 0.35% | 7.08% | -3.55% | 3378.81% |